Literature DB >> 14000409

Withdrawal of perphenazine in chronic schizophrenia.

C B WHITTAKER, R M HOY.   

Abstract

Entities:  

Keywords:  PERPHENAZINE; SCHIZOPHRENIA

Mesh：

Substances：

Year:  1963        PMID： 14000409     DOI： 10.1192/bjp.109.460.422

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

Review 1.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

2.  Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia.

Authors:  E Peselow; B Angrist; A Sudilovsky; J Corwin; J Siekierski; F Trent; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

Review 4.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

Review 5.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 6.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

Review 7.  Influence of placebo effect in mental disorders research: A systematic review and meta-analysis.

Authors:  Rodrigo Fernández-López; Blanca Riquelme-Gallego; Aurora Bueno-Cavanillas; Khalid S Khan
Journal:  Eur J Clin Invest       Date:  2022-02-27       Impact factor: 5.722
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.